首页> 外文期刊>BMC Infectious Diseases >Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary
【24h】

Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary

机译:来自匈牙利国家淋病奈瑟菌参考实验室的患者中淋病奈瑟菌分离株的发生率和抗菌药敏性

获取原文
           

摘要

Background The Hungarian national guidelines for the treatment of gonorrhoea were published in 2002 but are now widely considered to be outdated. Improved knowledge is needed with respect to the epidemiology and antimicrobial susceptibility of Neisseria gonorrhoeae strains currently circulating in Hungary not least for the construction of updated local recommendations for treating gonorrhoea. European guidelines are based mostly on western European data raising concerns locally that recommended treatments might not be optimised for the situation in Hungary. We report our recent study on the distribution of antibiotic resistance in various Hungarian (East European) Neisseria gonorrhoeae strains isolated from patients with gonorrhoea over the past four years. Methods Between January 2010 and December 2013, isolates of N. gonorrhoeae were obtained from sexually active individuals during medical examination at the STD Center of Semmelweis University in Budapest. The minimal inhibitory concentrations (MIC) of azithromycin, cefixime, ceftriaxone, ciprofloxacin, penicillin, tetracycline and spectinomycin were determined to establish the antimicrobial susceptibility of the strains currently circulating in patients that attend our clinic. Results Among the 9097 patients tested, 582 had an N. gonorrhoeae infection as detected by culture. The isolates were all sensitive to ceftriaxone and spectinomycin and 581/582 strains were sensitive to cefixime. In contrast, the number of detected strains with elevated azithromycin MIC did increase over the time period examined to approximately 16% in 2013. There was a high percentage of detected resistance to penicillin (77%), tetracycline (86%), and ciprofloxacin (66%) in the isolates examined in this study. Conclusion Current European guidelines recommend 2?g azithromycin in addition to 500?mg ceftriaxone as first choice therapy for gonorrhoea. For the purposes of revising the Hungarian national treatment guidelines, apparent increasing resistance to azithromycin during the last four years should be accounted for. It is also clear that penicillin, tetracycline and ciprofloxacin are inappropriate treatment measures at least locally. We also recommend that culture should form part of the diagnostic pathway of gonorrhoea, followed by antibiotic susceptibility testing with MIC determination. This will provide valuable continued monitoring of antibiotic resistance development in strains of Neisseria gonorrhoeae circulating in Hungary.
机译:背景技术匈牙利的淋病国家治疗指南于2002年发布,但现在被普遍认为已过时。目前需要在匈牙利流行的淋病奈瑟氏球菌菌株的流行病学和抗菌药敏性方面有更多的知识,尤其是对于建立更新的治疗淋病的当地建议。欧洲指南主要基于西欧数据,这引起了当地的担忧,即可能无法针对匈牙利的情况优化推荐的治疗方法。我们报告了过去四年来,从淋病患者中分离出的各种匈牙利(东欧)淋病奈瑟菌菌株对抗生素耐药性分布的最新研究。方法2010年1月至2013年12月期间,在布达佩斯塞默维斯大学STD中心进行医学检查时从性活跃个体中分离出淋病奈瑟菌。确定了阿奇霉素,头孢克肟,头孢曲松,环丙沙星,青霉素,四环素和壮观霉素的最低抑菌浓度(MIC),以确定目前在我们诊所就诊的患者中传播的菌株的抗菌药敏性。结果经检测,在9097名患者中,有582名患有淋病奈瑟菌。分离株对头孢曲松和壮观霉素均敏感,而581/582菌株对头孢克肟敏感。相比之下,2013年检测到的阿奇霉素MIC升高菌株的确增加了约16%。检测到的对青霉素(77%),四环素(86%)和环丙沙星(在这项研究中检测到的分离物中占66%)。结论当前的欧洲指南建议在500毫克头孢曲松外加2克阿奇霉素作为淋病的首选疗法。为了修订《匈牙利国民待遇准则》,应考虑最近四年来对阿奇霉素的明显耐药性增加。同样清楚的是,青霉素,四环素和环丙沙星至少在局部是不合适的治疗措施。我们还建议培养应成为淋病诊断途径的一部分,然后通过MIC测定进行抗生素敏感性测试。这将提供有价值的持续监测在匈牙利流通的淋病奈瑟氏球菌菌株中抗生素耐药性发展的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号